Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung

We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topica...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathyanarayanan, Vishwanath, Lokesh, Kadabur Nagendrappa, Channaviriappa, Lakshmaiah Kuntejowdahalli, Jacob, Linu Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080647/
https://www.ncbi.nlm.nih.gov/pubmed/25006299
http://dx.doi.org/10.4103/0971-5851.133736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080647/
https://www.ncbi.nlm.nih.gov/pubmed/25006299
http://dx.doi.org/10.4103/0971-5851.133736

Ejemplares similares